STEMPOINT CAPITAL LP
•CIK: 1952142•Filing: Q4 2025
**StemPoint Capital LP** manages $554M across a concentrated portfolio of 75 positions. The fund exhibits a significant allocation to biotechnology and emerging science themes, highlighted by top holdings such as ABVX at $52.8M and SRRK at $39.1M. Further substantial exposure includes SNDX ($28.1M) and GPCR ($24.4M). This structure suggests a deep, conviction-driven approach targeting high-growth, specialized sectors.
Total AUM
$553.8M
+ $26.3K in options
QoQ Performance
+36.6%
Positions
74
+ 1 option
Top 10 Concentration
45.8%
Latest Filing
Q4 2025
Top Holdings Allocation
ABVX
SRRK
SNDX
ABVX9.5%
SRRK7.1%
SNDX5.1%
GPCR4.4%
ACLX3.9%
ROIV3.8%
TERN3.1%
TWST3.0%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other97.4%
Healthcare2.6%
🚪 Exited Positionssold since Q3 2025
+32 more exited positions
Changes from Q3 2025
NEW32 new positions
↑27 increased
↓16 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023